AeA 2007 Awards Presentation “THE DIACEPH TEST”

Submitted by: Stephen Dolle WWW.DOLLECOMMUNICATIONS.COM

Newport Beach, CA Tel. (949) 642-4592 4/29/2020 By: Stephen Dolle 1

Table of Contents

• • • • • • • • Categories for Nomination – Slide 3 Message from its inventor – Slide 4 Awards Submission List – Slide 5 Introduction – Slide 6 Description – Slide 7 Technology Innovation – Slide 8 Peer Review – Slide 9 End of Presentation – slide 10 4/29/2020 By: Stephen Dolle 2

Categories for Nomination

• • • [X] Software/Internet [X] Computers & Related Products [X] Medical Device Technology/Instrumentation 4/29/2020 By: Stephen Dolle 3

Message from the Inventor

Innovation is defined as “the act of creating and introducing something new or better.” The DiaCeph Test has been and remains the only standard in-vivo means to monitor patients in ordinary real-time. The only ingredient remaining for its full adoption is “will.” We ask for your passion and “will.” 4/29/2020 By: Stephen Dolle 4

Awards Submission Contains:

• • • • • • The Award Application included: An Introduction & Message from its Inventor Product Description; Features and Benefits Product literature, Power Point (2), specification sheets, peer review and adoption, and financials Discussion of innovative aspects of invention When product will be introduced Supporting documents 4/29/2020 By: Stephen Dolle 5

Introduction

The following files were included: • The DiaCeph Test and its Inventor appear at the 1999 (FDA) STAMP Conference in Washington, D.C.

• • Dolle and DiaCeph appear in the Orange County Business Journal, March 1999 Favorable DiaCeph Test financials move development forward 4/29/2020 By: Stephen Dolle 6

Description

The following files were included: • • • • • DiaCeph Test Description (Word) Standard Paper Monitoring Form (PDF) Paper Form (Blank) Graph (PDF) Shunt Technology: A Perspective (PPT) DiaCeph Test System Presentation (PPT) 4/29/2020 By: Stephen Dolle 7

Technology Innovation

• The following files were included: DiaCeph’s innovative new Shunt Selection Model: Tandem DiaCeph & ICP Tap • Sample Patient Graph – Paper Results. Just imagine what a computer program would do!

4/29/2020 By: Stephen Dolle 8

Peer Review

• • • • The following files were included: Dr. Eldon Foltz comments on DiaCeph in Orange County Business Journal, March 1999 (PDF) Food & Drug Administration (STAMP) takes liking to new DiaCeph Test 1999 (PDF) UCI’s Elizabeth Parker, Ph.D. gives favorable review of DiaCeph, Jan. 2000 Email (PDF) Vygon U.S. Vice President praises DiaCeph’s Shunt Selection Model, 2006 Email (Outlook) 4/29/2020 By: Stephen Dolle 9

End of Presentation

4/29/2020 For more information contact: Stephen Dolle DOLLE COMMUNICATIONS 3908 ½ River Avenue Newport Beach, CA 92663 Tel. (949) 642-4592 By: Stephen Dolle 10